Financials | Financial Services | Capital Markets | Asset Management & Custody Banks
NASDAQ | Common Stock
Arya Sciences Acquisition Corp IV does not have significant operations.
The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
It focuses on acquiring North American or European companies in the life sciences and medical technology sectors.
The company was incorporated in 2020 and is based in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Sep 30, 23 | -0.06 Decreased by -136.06% | - |
| Jun 30, 23 | 0.05 Increased by +614.00% | - |
| Apr 6, 23 | 0.05 Increased by +600.00% | - |
| Dec 31, 22 | -0.09 Decreased by -48.17% | - |
| Nov 7, 22 | 0.17 Increased by +162.96% | - |
| Aug 8, 22 | -0.01 Increased by 0.00% | - |
| May 13, 22 | -0.01 Increased by 0.00% | - |
| Mar 31, 22 | -0.06 Decreased by -440.54% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 0.00 Decreased by N/A% | -455.07 K Decreased by -106.96% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | 381.51 K Increased by +537.53% | Increased by +N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -3.14 M Decreased by -1.75 K% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -1.71 M Decreased by -55.72% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | 6.54 M Increased by +228.45% | Increased by +N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -87.20 K Increased by +46.32% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -169.65 K Increased by +19.31% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -1.10 M Decreased by N/A% | Decreased by N/A% - |